CardioComm Solutions, Inc.
EKGGF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $44 | $72 | $100 | $170 |
| % Growth | -38.8% | -28% | -41.3% | – |
| Cost of Goods Sold | $109 | $17 | $6 | $15 |
| Gross Profit | -$77 | $55 | $94 | $156 |
| % Margin | -174.6% | 76.6% | 93.6% | 91.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $183 | $36 | $153 | $194 |
| SG&A Expenses | $183 | $182 | $153 | $194 |
| Sales & Mktg Exp. | $0 | $146 | $0 | $0 |
| Other Operating Expenses | -$136 | $0 | $27 | -$20 |
| Operating Expenses | $47 | $182 | $179 | $174 |
| Operating Income | -$173 | -$127 | -$86 | -$18 |
| % Margin | -393.1% | -175.8% | -85.7% | -10.7% |
| Other Income/Exp. Net | $3 | $2 | $68 | -$74 |
| Pre-Tax Income | -$170 | -$124 | -$18 | -$93 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$122 | -$124 | -$18 | -$93 |
| % Margin | -276.6% | -172.5% | -18.1% | -54.4% |
| EPS | -0.001 | -0.001 | -0 | -0.001 |
| % Growth | -66.7% | -500% | 80% | – |
| EPS Diluted | -0.001 | -0.001 | -0 | -0.001 |
| Weighted Avg Shares Out | 195,819 | 193,253 | 193,074 | 180,089 |
| Weighted Avg Shares Out Dil | 195,819 | 193,074 | 193,074 | 180,089 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $10 | $8 | $6 | $38 |
| Depreciation & Amortization | $7 | $1 | $7 | $8 |
| EBITDA | -$149 | -$133 | -$5 | $94 |
| % Margin | -338.9% | -184.7% | -5.1% | 55.2% |